Literature DB >> 36157142

Teratoid Hepatoblastoma with Multi-Lineage Differentiation: An Uncommon Histological Variant and Review of Literature.

Mayur Parkhi1, Suvradeep Mitra1, Debajyoti Chatterjee1, Nitin J Peters2.   

Abstract

Background: Teratoid hepatoblastoma is an uncommon but well-recognized variant of mixed hepatoblastoma. Case report: A one-year female child presented with palpable and progressively increasing right abdominal mass for 3 months. The contrast-enhancing computed tomography (CECT) abdomen revealed a large heterogeneous hepatic mass measuring 12 × 6.6 × 6 cm. Histopathological examination of the resected specimen showed a mixed hepatoblastoma (epithelial and mesenchymal) with teratoid features and multi-lineage differentiation (all three germ cell layers). A focus showed embryonal rhabdomyosarcomatous element.
Conclusion: Teratoid hepatoblastoma can show a wide range of heterologous differentiation that may pose a significant diagnostic dilemma. Such a broad spectrum has not been described in the literature previously. An appropriate immunohistochemical panel may be needed to identify and delineate the various heterologous differentiation to clinch the correct diagnosis. Secondary somatic malignancy such as rhabdomyosarcoma can develop in a teratomatous element.
© 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AFP, alpha-feto protein; CECT, contrast enhancing computed tomography; GFAP, glial fibrillary acidic protein; GPC3, glypican 3; GS, glutamine synthetase; HB, hepatoblastoma; IVC, inferior vena cava; SCUD, small cell undifferentiated; alpha-fetoprotein; hepatoblastoma; neuroendocrine; rhabdomyosarcoma; tHB, teratoid hepatoblastoma; teratoid variant

Year:  2022        PMID: 36157142      PMCID: PMC9499848          DOI: 10.1016/j.jceh.2022.04.005

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  22 in total

1.  Mixed hepatoblastoma with teratoid features in an adult.

Authors:  Shu-Hui Zhang; Ai-Min Xu; Wan-He Lin; Xiao-Yun Zhang
Journal:  Pathology       Date:  2007-08       Impact factor: 5.306

Review 2.  Management of hepatoblastoma: an update.

Authors:  Nathalie Kremer; Ashley E Walther; Gregory M Tiao
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

3.  CDX2 highlights mucinous epithelium in hepatoblastoma with teratoid components.

Authors:  Rong Fan; Jingmei Lin
Journal:  Fetal Pediatr Pathol       Date:  2012-09-24       Impact factor: 0.958

4.  Teratoid hepatoblastoma. The nosologic dilemma of solid embryonic neoplasms of childhood.

Authors:  C Manivel; M R Wick; P Abenoza; L P Dehner
Journal:  Cancer       Date:  1986-06-01       Impact factor: 6.860

5.  Teratoid Hepatoblastoma With Yolk Sac-Like and Neuroendocrine Elements.

Authors:  Jacob A Smith; Sarangarajan Ranganathan
Journal:  Pediatr Dev Pathol       Date:  2020-05-19

6.  Growing teratoma syndrome in mixed hepatoblastoma with teratoid features.

Authors:  Sanjeev Khera; Vikram Singh; Badal Parikh; Karunesh Chand
Journal:  BMJ Case Rep       Date:  2021-03-17

7.  Teratoid hepatoblastoma: multidirectional differentiation of stem cell of the liver.

Authors:  L Kim; Y N Park; S E Kim; T W Noh; C Park
Journal:  Yonsei Med J       Date:  2001-08       Impact factor: 2.759

Review 8.  Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation.

Authors:  Rebecka L Meyers; Greg Tiao; Jean de Ville de Goyet; Riccardo Superina; Daniel C Aronson
Journal:  Curr Opin Pediatr       Date:  2014-02       Impact factor: 2.856

9.  Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases.

Authors:  Debra L Zynger; Anita Gupta; Chunyan Luan; Pauline M Chou; Guang-Yu Yang; Ximing J Yang
Journal:  Hum Pathol       Date:  2007-10-18       Impact factor: 3.466

10.  Mixed hepatoblastoma and teratoma of the liver in a 3-year-old child: a unique combination and clinical challenge.

Authors:  Alexander Moll; Alexander Krenauer; Uta Bierbach; Holger Till; Wolfgang Hirsch; Ivo Leuschner; Nicole Schmitz; Christian Wittekind; Thomas Aigner
Journal:  Diagn Pathol       Date:  2009-11-12       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.